ALNY vs PSNL · P/E 76, rev $1.29B vs rev $37.8M
Alnylam Pharmaceuticals Inc (ALNY) versus Personalis Inc (PSNL) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Personalis Inc (PSNL) is a diagnostics & research company listed on NASDAQ.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported PSNL revenue for 2026-06-30 was $37.8M. Net income was -$61.7M. PSNL currently screens at market cap $1.02B.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. PSNL currently screens at market cap $1.02B.
Not investment advice. Open the ALNY and PSNL stock pages for the full models.
Not investment advice.